Altair
Skip to content

Trading Analysis Report: NOW

Analysis date: 2026-10-21 · Model: claude-opus-5-5 · AI-generated, not financial advice.

  • Analysis date: 2026-10-21
  • Rating: Underweight
  • Generated: 2026-10-21 12:29:33
  • TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Underweight

Executive Summary: Reduce NOW to no more than 50% of target weight (target portfolio weight, not current holding) before the Q3 print. Do not short and add no new money. Sell down to 75% of target today, then place the second piece as a 154.20 limit backed by a market-on-close order at the deadline. The deadline is two sessions before the confirmed report date: Monday Oct 26 if the retail-sourced Oct 28 holds, or tomorrow's close if the date cannot be confirmed. Go below half if a 12% gap (or the options-implied move, if larger) and a 20% gap across your whole software/AI sleeve are not tolerable. Go to 25% only if pre-written adverse filing or guidance findings appear. Risk levels for what remains: 144.83 (10 EMA) is a warning flag, a daily close below 136.22 (50 SMA) is a cut, and a resting stop-market at 132.36 (daily SuperTrend) is the last line. Horizon is 1-3 months, with a 140 objective.

Current Price: 153.23

Price Target: 140.2

Confidence: Medium

Time Horizon: 1-3 months

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: I'll open, since nobody else has spoken. I'll also pre-empt what I expect from both of you, because I think the cautious camps will each get something wrong here.

First, why selling is the bold call. NOW has rallied about 85% off the April closing low, to 153.23, its highest close since late December. The crowd is euphoric. Seventeen of the eighteen labeled StockTwits posts are bullish, they come from only twelve authors, and one person posted four emoji-only bullish messages in about two minutes. When labeled sentiment is 94% one way, the easy move is to hold full size and ride the momentum. The harder and better move is to sell into that demand at a pre-committed level, 154.20 to 156.5, right where sellers already showed up on October 16. That day NOW ran to 154.20 and closed at 141.97 on 15.5 million shares.

Now the setup. The daily TD-9 is complete, the daily z-score is +2.31, the close is above the upper Bollinger band, and the last three up sessions came on fading volume. Add the earnings report, which retail says is around October 28 and I can't verify, and the October 29 FOMC. Over the last ten months the stock has had three gap-downs of 11.5%, 9.9% and 17.7%. A gap of that size from here lands around 126 to 136, straight through the 132.36 daily SuperTrend stop with no chance to exit. The upside to the monthly flip at 169 is about 10%. So the plan is risking something like 13 to 18% for 10%, and the downside can't be managed with a stop. That is an unattractive payoff.

The fundamentals add to it. Cost of revenue grew 61.5% year over year while revenue grew 24%. Gross margin fell from 77.5% to 70.7% and operating income dropped 55%. Cash flow doesn't fit a story where the cost step is purely non-cash. Liabilities to equity went from 1.08x to 1.53x, and the current ratio is 0.70. Forward P/E of 30.6 rests on a non-GAAP EPS about three times the GAAP figure, and I have no SBC bridge. Insiders sold about $6.3M in 2026 as the stock climbed from the high 80s to the high 140s. The CEO's $3M purchase near $105 was the only open-market buy.

Now the cautious camps. If the conservative analyst argues for selling everything or shorting, I disagree. The weekly SuperTrend is up with a stop at 106.12, OBV is at a 30-day high, MACD is above its signal, and RSI is 65.8, still short of 70. The October 16 reversal was fully recovered within three sessions. Shorting that is paying for a view the primary trend contradicts, and a good print could squeeze you. That's why the plan trims to about 50% rather than shorting. I'm keeping real exposure to the upside, including a run through 154.20 toward 156.5 and possibly 169. Half-in is a position with convexity.

If the neutral analyst says to hold because the weekly and monthly TD counts are early and RSI isn't overbought, my answer is that those are slow-horizon tools. The question is the next two weeks, and for that horizon the daily signals and the event calendar matter more. A weekly z-score of 1.64 doesn't protect you from a gap. The sector-rally story doesn't either. The only news is a 3% software bounce alongside Palantir, with Salesforce flat. That looks sector-driven, not NOW-specific, and sector bounces fade. Even the retail bulls are hedging. One poster expects a run to 160 and then "a crapshoot," and plans to take profits. When the optimists are planning exits, I want mine placed first.

The macro doesn't help. Polymarket prices no Fed cuts in 2026 at 97% and a 12% chance of a hike on the 29th. The probability of an AI-bubble burst is small at 9% but rose 3 points in a week. That caps multiple expansion for a stock at 10.8x sales and 96x GAAP earnings.

The plan also escalates on facts. If the filings show a late-June deal close, amortization under about $85M, or ex-acquisition cRPO growth under about 20%, I cut to 25%. Below the 10 EMA at 144.83, the 50 SMA at 136.22, or the daily SuperTrend at 132.36, I keep stepping down. And I don't average down into a gap. The cash from the trim is dry powder to redeploy after the print once the price stabilizes.

I'll be upfront about what I haven't verified. I don't have the earnings date, the deal close date, the SBC bridge or cRPO data, and the last bar may be partial. I'd confirm the date and finish the trim at least two sessions before the report. Even so, with those gaps, the edge belongs to selling half into strength and holding the rest. Aggressive Analyst: Several of your corrections land, so I'll start by giving those back.

Conservative, you're right that half a position isn't convex. It's the same bet at half the size, and I shouldn't have used the word. What the trim buys is a smaller loss in the bad case while I stay in the trade, which is risk budgeting, not an option payoff.

Neutral, you're right on the gap math. 153.23 less 11.5% is about 135.6, and less 9.9% is about 138.1, both above 132.36. Only a repeat of April's 17.7% goes through the stop, so my "126 to 136, straight through" overstated it. "Risking 13 to 18% for 10%" was also sloppy. 13.6% is the distance to the stop, not a gap size, and 169 isn't a cap. A good print can reach it in one session, which is exactly why I'm not shorting.

I'll also drop a few supporting points. Labeled NOW sentiment is 17 of 17 and comes from one green session, so it isn't a crowding signal I should lean on. $6.3M of insider sales against a $158B market cap is noise. I can't prove sector bounces fade, though I'd note the only NOW-specific story, Arc GA, comes from retail posts the news feed doesn't corroborate. The macro isn't a thesis either. Hike odds fell 18 points on the week.

What survives is narrower. Neutral's rule is the right one: slow tools set the bias and fast tools set the timing. The weekly SuperTrend at 106.12 and OBV at a 30-day high mean no short. The completed daily TD-9, the +2.31 z-score and the close above the 151.39 band mean don't carry full size into a print. I used the weekly and monthly tools inconsistently, but that was a framing problem, not a flaw in the trade.

On margins, Neutral says Q2 isn't news because the stock kept climbing after it. I agree, and that's why this isn't a short thesis. It does mean the stock has gone from about 90 in late June to 153 with those margins in view. Gross margin has gone from 78.9% to 70.7% across the quarters we can see, cost of revenue grew 61.5% against 24% revenue growth, and operating margin fell to 4.1%. Q3 has to show that stabilizing while the price already assumes it does. Whether the acquisition's full-quarter costs stack on top is still inference, and the filings can settle it.

Now the actual disagreement, 50% versus 25%. I side with Neutral against a 25% default, but the dispute is smaller than the rhetoric. Going from 100% to 50% is the big decision. Going from 50% to 25% moves about 2.5 points of standard-weight value on a 10% up gap, 3 points on a 12% down gap and 4.5 on an 18% gap. That's real but modest, so evidence should decide it, not a standing preference. Conservative, I agree the filing checks happen today, before sizing. But cutting to 25% because a check couldn't be completed treats an unknown as bad news, which is the mirror image of holding because RSI is under 70. Keep 50% as the default, since it already prices the unknown. Go to 25% on confirmed evidence: a late-June close, amortization too small to explain the cost step, or weak ex-acquisition cRPO.

On execution, you're both partly right. Neutral is right that 154.20 is 0.6% above the close, with a 6.28 ATR, and will fill easily. Conservative is right that the risk is a pullback starting tomorrow with only three or four sessions left. So sell a first quarter now, put the second quarter on limits at 154.20 to 156.5, set a hard deadline at the close two sessions before the report (the 26th if the 28th is confirmed), and sell whatever's left at market. That's what the plan should have said. Today's bar may also be partial, so don't treat 153.23 as final.

I also take these: - Neutral's two-number sizing: pick a loss you can tolerate at a 12% gap and one you can survive at 18%. - Keeping stops and size separate. The ladder at 144.83, 136.22 and 132.36 handles drift, and position size handles the gap. - Defining standard weight as target weight. If you rode the 85% run without rebalancing, getting to 50% of target may mean selling well over half of what you hold. I can't see the book, so apply that to your own position. - Conservative's warning that gaps aren't only earnings. The December 15 drop is proof, so the cash isn't earmarked for NOW and nothing gets redeployed mechanically.

On the hedge, a put spread covering the 126 to 136 zone is the only thing that changes the payoff shape. But premium into a known event embeds the expected move, I've seen no pricing, and a collar gives up the upside I'm keeping. It's optional, not a condition.

So the case is simpler than my opening made it. This stock moves 10 to 18% on events, it's stretched on every fast indicator, and two catalysts may land on the same open: earnings reaction and the FOMC, if both dates hold, and neither is verified. Selling half into strength costs about 5 points of position value if the print gaps up 10%. It saves 6 to 9 points if it gaps down 12 to 18%. That's a cheap price for surviving the wrong side while keeping the weekly uptrend working for you. Aggressive Analyst: Let me start by giving back what Neutral earned. My closing tally was stacked. I set a 10% up gap against 12 to 18% down gaps and called the trim cheap. If the print gaps up 12 to 18%, the trim costs 6 to 9 points, and we have no base rate for direction. So I'm dropping "cheap." The trim buys variance reduction, plus a small edge from selling into a stretched daily tape. I'm also dropping "the price already assumes stabilization," since the 89.52 low came before the Q2 report and the market may have seen those margins and bought anyway. The one-headline news feed not backing Arc tells us nothing either way. And "six straight quarters of gross-margin decline" can't be verified with Q4 missing. What we can see is five observed quarters, each lower than the last, and I'd write it that way.

Where I still part from Conservative is the claim that variance reduction alone pushes you toward 25%. Neutral already gave the reductio: if the trim is free, go to zero. It isn't free because NOW has positive drift, with a rising 50 SMA, an up weekly SuperTrend and OBV at a 30-day high. Every point of weight you sell gives some of that up. The daily stretch signals justify selling into the next week or so, but they don't justify abandoning a position that could be there for a regime flip. A 10% gap up lands near 168.6, almost exactly on the 169 monthly flip. If the print gets there, the remaining half is what's working for you. So 50% is a ceiling set by the 12/18 test, and the weekly trend is why I'd let it be 50 and not reach for 25. I can't prove 50 beats 40, and I won't pretend to.

On the ladder, Conservative is right that you can't sell at 144.83 on a gap to 138. But that's the argument for sizing to the gap, which is what we've done. The rungs were never gap protection. The June round trip from 135.86 to 89.52 is a drift story, exactly what the 10 EMA, 50 SMA and 132.36 steps are for. The structure now, with two months of higher lows, also differs from a one-day spike. I'd respect that episode by keeping the ladder strict, not by selling more today.

Neutral's point that about a third of the gross-margin slide predates the acquisition quarter actually helps the Sell. It means the filing checks work in one direction. A bad check takes me to 25%. A clean one never takes me above 50. Conservative's wording is right: passing doesn't license anything, it only removes a reason to go lower.

On execution, I'll fold. A limit at 154.20 is a 0.6% bet, and 156.5 was greed on my part. I'd rather be bold on the thesis than greedy on a limit. Sell the first quarter today, because the date is unverified and Meta reports tonight. Put the second quarter at 154.20. Let information set the deadline: Monday's close if the 28th is confirmed, Friday's if it isn't. The difference is small, because the limit only goes unfilled if the stock is falling, and in that case the quarter sold today already did its job.

Neutral's third point is the most useful new thing in the room, and I had it wrong. Trimming NOW doesn't reduce exposure to the Meta read-through, the FOMC or a sector reversal if the book is full of other software and AI names. So judge the 50% against the whole sleeve, and don't park proceeds in more high-beta software.

I do want to push on the re-entry rule, because that's where aggressive capital earns its keep. Write it now, not at the open after a gap. If the stock holds above the 50 SMA at 136.22 after the print and the filings check out, that's a buy-back candidate. If it closes above 169, the monthly regime flips and all three timeframes point up. I'd rather pay up for that confirmation than sit out a breakout because I trimmed into the setup. If it gaps into the 126 to 136 zone with the weekly stop at 106 intact, that's where the dry powder gets evaluated, not spent automatically. Nothing is pre-committed, as Conservative asked, but the triggers are written down so the decision isn't improvised.

One calendar fix from me. I should stop saying earnings and the FOMC hit the same open. The decision may land on the 28th, ahead of a reaction session on the 29th. That's one more date to confirm.

So I back the Sell:

  • Today: sell a quarter of target weight.
  • Second quarter: limit at 154.20, with the deadline set by the confirmed earnings date.
  • Remaining position: hold up to 50%, subject to the 12/18 test, and cut to 25% on confirmed filing evidence.
  • Risk rules: use the ladder for drift and size for the gap. Don't average down, and don't redeploy mechanically.

It's a more modest plan than my opening, and a better one. Aggressive Analyst: Conservative has earned a few things, so I'll start there.

Conservative, you're right that the daily stop at 132.36 is 13.6% below the close, which sits between our 12 and 18 marks. One pair of numbers therefore covers both a gap and a ladder that fails to catch a fast drift, which is a cleaner way to run the test. You're also right about re-entry. Holding above 136.22 is true after a gap up and after a gap down, so it can't be a trigger. Neutral's version fixes that. After a gap up, rebuild in stages only if the stock holds the gap area for a few sessions. After a gap down, wait for a higher low and a close back above the 10 EMA, with the filings read. Nothing gets rebuilt before the print, even on a close above 169. I'm taking that and dropping mine.

On the rest, I side with Neutral. Eighteen as a floor doesn't work, because then 25 is the next floor, and a test you can fail by moving the assumption isn't a test. A 25% drop from 153.23 is about 115, right at the 200 SMA, with the weekly stop at 106 still intact. Use 20 for margin, apply it across the whole software and AI sleeve, and stop. If a 20% hit on half a target position is unsurvivable, the book had a sizing problem before NOW came into it.

Rounding down when the evidence is ambiguous is the mirror image of holding because RSI is under 70. Positive drift also doesn't rest on the weekly SuperTrend alone. The averages are stacked, the 50 SMA went from 123 to 136 in a month, MACD is above its signal, and OBV is at a 30-day high. The monthly SuperTrend is still down because it lags a stock that fell from 173 to 83. Its flip at 169 is about 10% away, and a 10% gap up lands near 168.6. I read that as a scoreboard for what a good print is worth, not a bearish vote.

Now the point I'll push hardest, Conservative. You said the unknowns all sit on the tail side, but an unknown has no side until someone resolves it. Take the unreconciled $5.15B of FCF. Subtract the three quarters we can see, 578, 1,529 and 473, and the figure implies roughly $2.6B in Q4'25. That's my arithmetic, and I can't say it's right. But the quarterly pattern is lumpy, with about 1.5B in each Q1 and about 500M in the Q2s, so a $2.6B quarter isn't absurd, and only the 10-K settles it. That's a missing quarter, not a red flag. Flat H1 FCF on 23% revenue growth is a real concern, and I'm not waving it away. But the SBC bridge, the deal terms and the amortization all live in documents that exist today. Confirmed adverse evidence takes me to 25%. An unfinished to-do list doesn't.

Neutral's arithmetic is the cleanest statement of why the print matters. Cost of revenue rose about $229M from Q1 to Q2 on about $217M of added revenue, so gross profit fell on higher sales. That justifies not carrying full size into Q3 gross margin. It doesn't justify abandoning the position.

One fix to the deadline. Conservative, you said all three sources fit this Thursday or Friday. I'm not sure that holds. The fundamentals report says usually the last week of October, which points to the 26th through the 30th and fits the retail 28th. But none of that is verified, which is the point. The date is a lookup, so do it today. If it isn't confirmed by tomorrow's close, finish the sale by tomorrow's close, not Friday's. A Friday fallback leaves the second quarter exposed if the print is Thursday evening. Being early costs about a point of target weight. Being late costs the whole quarter at the gap. I'm moving toward your instinct there.

I still say the ceiling is 50 and not 25. The trim is variance reduction plus a modest timing edge from selling a stretched daily tape. It isn't free, because drift is positive and every point I sell gives up some of it. A typical 10 to 12% down gap lands around 135 to 138, above the 132.36 stop. A half-size position absorbs that, and it's still there if the print takes the stock to the 169 flip.

So here is the plan. Before today's close, sell a quarter of target weight at market. Meta reports tonight and today's bar may be partial. Look up the report date, and read the 8-K and 10-Q for the deal close, amortization and ex-acquisition cRPO. Put the second quarter on a limit at 154.20 with the deadline above, and sell anything unfilled at market. Hold up to half of target, subject to the 12 and 20 tests across the sleeve, and cut to a quarter only on confirmed adverse filings. The ladder handles drift and size handles the gap. Don't short, don't average down, cancel resting buys, and don't commit the proceeds to NOW or to other high-beta software. Rebuild only under Neutral's one-world rules, after the print. I can't see the book, so measure all of this against target weight, not what you hold today.

Selling is the cheap part of this plan. The bold part is holding half through a print with a written exit, a written re-entry, and a position small enough that you can be wrong in either direction. I still back the Sell. Aggressive Analyst: Neutral, you've earned several of these, so I'll give them back first.

On the timing edge, I kept leaning on the stretched daily tape. The technical report itself reads the completed nine as a pause inside an uptrend, with RSI at 65.8, OBV at a 30-day high and the weekly z-score at 1.64. I'm dropping it. The reason to trim is the print: a stock that moves 10 to 18 percent on events, a gross margin that fell about four points in one quarter, and a forward EPS nobody here can bridge. The tape only tells me where a limit might fill. If it dips to 148 tomorrow, the second sale still happens. If it runs to 158, I don't chase the limit up.

The 25 percent triggers came with the trader's plan, and I defended them as if I knew where the 85 million and 20 percent figures came from. I don't, and ex-acquisition cRPO may only exist in the release or on the call. So write down what counts as adverse before anyone opens a filing, and treat silence as not adverse. If that means the 25 percent branch never fires, fine.

You're also right that "the whole quarter at the gap" was wrong. Late costs a quarter times the gap, 2.5 to 4.5 points on a 10 to 18 percent drop, and it pays you on a gap up. That's variance, and a date lookup ends the argument.

Endpoints beat quarters. If the position rode the rally from 83, it's probably above target, so the plan is 75 percent of target after the first sale and 50 after the second. If you're already at or under half, there's nothing to sell, and the instruction is no adds before the print.

On taxes, I'd let them choose the lots, not decide whether to trim. If you hold lots from before the December gap, they're underwater at 153, so sell those first. That harvests the loss and keeps the spring-low lots with the big gains. The re-entry window also falls inside 30 days of any sale, so the wash-sale rule may disallow those losses if you rebuy. That's one for whoever does your taxes.

Your December balance sheet read changes how I see the deal question. Assets up $4.2B, non-current assets up $2.1B and equity up $1.7B, in a quarter where current liabilities rose $2.6B and cash $1.0B, could well be a second transaction, possibly part stock. That's inference, like the June story. It means a clean answer on June doesn't clear the margin, and the filing read should cover every deal since the fall. It's also why I'm retiring free cash flow from my case. Conservative is right that $2.6B for Q4 is 1.7 times the biggest visible quarter, and "not absurd" isn't "plausible." I can't call it a red flag or comfort, so it stays out of both columns.

Conservative, I'll push on one mechanical point. You want the filing read done before the limit goes in. But the second chunk gets sold on both branches. Clean filings take you to 50 percent and adverse ones take you to 25, and both pass through selling the second chunk. The read only decides whether a third chunk follows. So do the read tonight, place the 154.20 limit before tomorrow's open, and if the read is adverse, convert the rest to a market sale. Waiting for the read can only cost a fill, particularly with Meta reporting tonight.

I agree the 50 SMA at 136.22 and the daily SuperTrend at 132.36 should be standing instructions, because the day after a gap is when people talk themselves out of their own rules. I'd keep the 10 EMA at 144.83 as a flag, not a sale. It's about one ATR away, it's the normal reset after a completed nine, and selling there pays round-trip costs for noise. The flag still does something concrete: no adds, resting buys cancelled, and a written check on whether this is drift or a gap.

"Up to half" does mean up to. If the 12 and 20 tests across the sleeve say a third, it's a third. For illustration only, with a 4 percent target, half is a 2 percent position and a 20 percent gap costs 0.4 percent of the portfolio. If that number bothers you, the position is too big, whatever I say about the weekly trend.

Here's where I'd still push both of you. The exit side of this plan has numbers, and the re-entry side needs the same standing. Otherwise "half" only ratchets down. Neutral's one-world rules are right, so pick the parameters tonight. After a gap up, that means holding the gap area for a set number of sessions, say three, before rebuilding in stages. After a gap down, it means a higher low and a close back above the 10 EMA, with the filings read. If the print takes the stock to the 169 flip and you never rebuild, you've turned a trim into a verdict on the company, and nobody in this room wants that.

So I still back the Sell. Look up the report date first, since if it's this week the second sale happens at tomorrow's open without waiting for 154.20. Write down what counts as adverse. Sell to 75 percent of target before today's close, choosing lots deliberately. Put the second piece on a 154.20 limit with the deadline at the close two sessions before the confirmed date, or tomorrow's close if you can't confirm it, and sell any remainder at market. End at no more than half of target, less if the 12 and 20 tests across the whole software and AI sleeve say so, and a quarter only on the pre-written adverse findings. Put the 50 SMA and SuperTrend rungs in as standing instructions, and write the rebuild rules now. No short, no averaging down, and don't earmark the proceeds for NOW or other high-beta software. The trim buys you the right to hold the other half with conviction, and that's the aggressive part of this plan.